RAC supplies reference standards for 10 Riluzole impurities, including Riluzole Impurity 1 and Riluzole Impurity 13. Every lot is released with a certificate stating HPLC purity, MS and 1H NMR data, produced under ISO 17034:2016 (ANAB, AR-2832). All items are scheduled on synthesis, typically 3-4 weeks. Pharmacopoeial items follow the monograph numbering (EP, USP, BP); non-pharmacopoeial items are characterised against the drawn structure, and can be re-qualified against your own method on request.
| Standard | CAS | Status | |
|---|---|---|---|
| Riluzole Impurity 1 | 88149-49-9 | On synthesis | |
| Riluzole Impurity 13 | 1133115-28-2 | On synthesis | |
| Riluzole Impurity 2 | 752969-85-0 | On synthesis | |
| Riluzole Impurity 3 | 142229-74-1 | On synthesis | |
| Riluzole Impurity 4 | 144631-82-3 | On synthesis | |
| Riluzole Impurity 5 | 235101-36-7 | On synthesis | |
| Riluzole Impurity 6 | 179070-90-7 | On synthesis | |
| Riluzole Impurity 7 | 1456696-94-8 | On synthesis | |
| Riluzole Impurity 8 | 1391054-04-8 | On synthesis | |
| Riluzole Impurity 9 | 1736-72-7 | On synthesis |
Prices are quoted per enquiry — pack size, documentation and shipping are confirmed together.
Metabolites, NDSRI nitrosamines and degradation products of Riluzole that no catalogue lists — typically 3–4 weeks from 10 mg to gram scale, released with the same certificate.